Michael Hartwig
Family Medicine · Perry, OKNPI 1457354201
Payments from drug & device makers
Across 145 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$458
- AstraZeneca$446
- Novo Nordisk$365
- Bayer$248
- Pfizer$220
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$114
- plus $610 from 18 others
What the payments were for
- Food & beverage$2,461100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 31 | $458 |
| AstraZeneca | 26 | $446 |
| Novo Nordisk | 21 | $365 |
| Bayer | 12 | $248 |
| Pfizer | 13 | $220 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $114 |
| Johnson & Johnson | 5 | $80 |
| Astellas Pharma US Inc | 3 | $80 |
| Biogen | 5 | $76 |
| Boehringer Ingelheim | 4 | $68 |
| Amgen | 2 | $39 |
| Ultragenyx Pharmaceutical Inc. | 2 | $37 |
| Exact Sciences | 2 | $34 |
| Merck | 2 | $29 |
| GSK | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $13 |
| Si-bone, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$2,461 in reported general payments places this provider in the 75th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 245 | $147,719 |
| OzempicSemaglutide | 127 | $131,997 |
| FarxigaDapagliflozin Propanediol | 201 | $114,527 |
| MounjaroTirzepatide | 69 | $77,276 |
| EliquisApixaban | 197 | $75,114 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 67 | $50,858 |
| RybelsusSemaglutide | 47 | $45,259 |
| XifaxanRifaximin | 13 | $41,761 |
| TrulicityDulaglutide | 26 | $26,571 |
| JanuviaSitagliptin Phosphate | 44 | $24,095 |
| EntrestoSacubitril/Valsartan | 53 | $21,632 |
| XareltoRivaroxaban | 34 | $18,519 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 48 | $16,051 |
| MyrbetriqMirabegron | 39 | $14,010 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 25 | $11,560 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $365 | $177,255174 claims |
| Boehringer IngelheimJardiance, Tradjenta | $68 | $154,569271 claims |
| AstraZenecaFarxiga | $446 | $114,527201 claims |
| Lilly USA, LLCMounjaro, Trulicity | $458 | $103,84795 claims |
| PfizerEliquis | $220 | $75,114197 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $28 | $55,44879 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $114 | $41,76113 claims |
| MerckJanuvia, Janumet | $29 | $33,65561 claims |
| Johnson & JohnsonXarelto | $80 | $18,51934 claims |
| Astellas Pharma US IncMyrbetriq | $80 | $14,01039 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Perry
- Carl GriffinOklahoma City$28.2M
- Lisa ConneryNorman$15.6M
- Kyle RicknerYukon$14.7M
- Robert LockwoodYukon$8.6M
- Steven CoxNorman$6.9M
- Alexander FrankOklahoma City$3.1M
- Rachel AndersonNorman$2.8M
- Robert WestcottLindsay$1.6M
- Charles LunnOklahoma City$1.4M
- Jeffrey ChasteenTulsa$820K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.